CanFite Biopharma (CANF)
(Delayed Data from AMEX)
$1.98 USD
-0.04 (-1.98%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.96 -0.02 (-1.01%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
09/26/2024
Time: -- |
6/2024 | $-0.36 | 0.00% |
Earnings Summary
For their last quarter, CanFite Biopharma (CANF) reported earnings of -$0.31 per share, missing the Zacks Consensus Estimate of -$0.27 per share. This reflects a negative earnings surprise of 14.81%. Look out for CANF's next earnings release expected on September 26, 2024. For the next earning release, we expect the company to report earnings of -$0.36 per share, reflecting a year-over-year increase of 10%.
Earnings History
Price & Consensus
Zacks News for CANF
Can-Fite Biopharma Ltd (CANF) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
CANF: What are Zacks experts saying now?
Zacks Private Portfolio Services